Related Experiment Video

Updated: Sep 10, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K

Erratum: Developing a minimally invasive gene therapy for multiple sclerosis

Paul J H Nijhuis, Maurits Romijn, Roy Honing

    Molecular Therapy. Methods & Clinical Development
    |August 21, 2025
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1016/j.omtm.2025.101504.].

    More Related Videos

    Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
    05:55

    Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

    Published on: October 3, 2011

    61.5K
    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
    06:48

    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

    Published on: August 7, 2015

    21.5K

    Related Experiment Videos

    Last Updated: Sep 10, 2025

    Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
    06:51

    Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

    Published on: August 10, 2018

    7.8K
    Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
    05:55

    Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

    Published on: October 3, 2011

    61.5K
    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
    06:48

    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

    Published on: August 7, 2015

    21.5K

    Related Concept Videos

    Gene Therapy00:59

    Gene Therapy

    25.8K
    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
    25.8K
    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    314
    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    314

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Sema3A Interference on Cerebellum-Dependent Motor Associative Learning and Memory.

    International journal of molecular sciences·2026

    Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis.

    Acta neuropathologica·2026

    Microglial states associate with lesion dynamics in multiple sclerosis.

    Cell reports·2026

    Human microglial transitions at the Aβ-tau inflection point associate with divergent pathways to dementia and resilience.

    Nature medicine·2026

    Foamy microglia link oxylipins to disease progression in multiple sclerosis.

    Nature neuroscience·2026

    Protocol for isolating viable human central nervous system T cells.

    STAR protocols·2026

    Characterization and quantitation of baculoviral DNA in rAAV vectors produced in Sf9 cells.

    Molecular therapy. Methods & clinical development·2026

    In vivo delivery of a fluorogenic antisense oligonucleotide into human leukocytes in a humanized mouse model system.

    Molecular therapy. Methods & clinical development·2026

    Development of high-throughput analytical methods for characterization and quantitation of rAAV genome integrity.

    Molecular therapy. Methods & clinical development·2026

    Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated.

    Molecular therapy. Methods & clinical development·2026

    Targeted inhibition of ELANE expression using adenine base editing to treat severe congenital neutropenia.

    Molecular therapy. Methods & clinical development·2025

    AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administration.

    Molecular therapy. Methods & clinical development·2025

    Inhalable Nanocrystal-in-Microparticle of Linezolid in Pulmonary Tuberculosis.

    International journal of nanomedicine·2026

    Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence.

    International journal of nanomedicine·2026

    Integrated bioinformatics and experimental validation reveal lucanthone as a promising therapeutic agent targeting core genes in psoriasis.

    International immunopharmacology·2026

    Real-World Treatment Patterns in Patients with Spinal Muscular Atrophy Receiving Multiple Disease-Modifying Therapies.

    Advances in therapy·2026

    Native T1 for Diagnosis and Risk Prediction in Amyloid Transthyretin Cardiomyopathy: An Observational Study on 1,675 Subjects.

    JACC. Cardiovascular imaging·2026

    Biomarker-Guided Diagnosis of Riboflavin Transporter Deficiency Presenting as Seronegative Myasthenia Gravis: A Short Report from a Consanguineous Family.

    Genetic testing and molecular biomarkers·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us